Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PLTR vs MRNA✓SelectedUSD · MRNAPLTR vs MRNA performance historyLatest closeAs of-1.91%11/19
Stock and ETF performance explorer

PLTR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+13.6%
MRNA return
+318.7%
Excess return
-305.1%
Maximum drawdown
-33.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.9%+1.3%-3.2%-1.9%
7D-10.4%-13.8%+3.4%-10.0%
30D-20.2%-17.7%-2.5%-19.8%
3M-12.3%+14.3%-26.6%-12.6%
6M+13.6%+336.0%-322.4%+7.4%
All+13.6%+318.7%-305.1%+7.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling